Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/3/2025

Ganciclovir Dosing and Administration for CMV Treatment

Introduction to Ganciclovir Dosing

  • The Infectious Diseases Society of America recommends ganciclovir 2.5 mg/kg IV every 24 hours for induction therapy in patients with GFR 46 mL/min requiring CMV treatment 1, 2
  • For a patient with GFR 46 mL/min, the recommended induction dosing is 2.5 mg/kg IV every 24 hours, as they fall into the 25-49 mL/min category 1, 2

Dosing Algorithm Based on Renal Function

  • The Infectious Diseases Society of America provides clear dose adjustments for ganciclovir based on creatinine clearance (which approximates GFR) 1, 2
  • The dosing algorithm for induction therapy is as follows:

Maintenance Therapy After Induction

  • The maintenance dosing also requires adjustment based on renal function 1, 2
  • The dosing algorithm for maintenance therapy is as follows:
  • For a patient with GFR 46 mL/min, the recommended maintenance dosing is 1.25 mg/kg IV every 24 hours 1, 2

Standard Induction Duration

  • The standard induction duration is 14-21 days for CMV retinitis and disseminated disease 3
  • For CMV encephalitis, the induction duration should be extended to 2-3 weeks, and combination therapy with foscarnet should be considered 3

Alternative: Valganciclovir Consideration

  • If oral therapy is appropriate after initial IV treatment, valganciclovir dosing for GFR 40-59 mL/min is 450 mg every 12 hours for induction and 450 mg daily for maintenance 5
  • For GFR 25-39 mL/min, the valganciclovir dosing should be reduced to 450 mg daily for induction and 450 mg every other day for maintenance 5

Treatment Failure and Resistance

  • With long-term therapy, ganciclovir-resistant CMV strains can emerge 3
  • For resistant infections or treatment failures, consider foscarnet or combination therapy: ganciclovir 5 mg/kg IV every 12 hours PLUS foscarnet 60 mg/kg IV every 8 hours for 3 weeks 3
  • This combination achieved improvement or stabilization in 74% of HIV patients with CMV encephalitis or myelitis 3